Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Simple item page
dc.contributor.authorSezer, A.
dc.contributor.authorOzyilkan, O.
dc.date.accessioned2020-10-20T09:02:57Z
dc.date.available2020-10-20T09:02:57Z
dc.date.issued2019
dc.identifier.endpageS559en_US
dc.identifier.issn1556-0864en_US
dc.identifier.issue10en_US
dc.identifier.startpageS558en_US
dc.identifier.urihttps://www.jto.org/article/S1556-0864(19)31849-0/pdf
dc.identifier.urihttp://hdl.handle.net/11727/4936
dc.identifier.volume14en_US
dc.identifier.wos000492162203082en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.jtho.2019.08.1166en_US
dc.relation.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectALK positiveen_US
dc.subjectROS1 positiveen_US
dc.subjectLorlatiniben_US
dc.subjectAdvanced stage lung canceren_US
dc.titleLorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkeyen_US
dc.typeConference Objecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PIIS1556086419318490.pdf
Size:
419.92 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos Açık Erişimli Yayınlar
Wos İndeksli Yayınlar Koleksiyonu